RNAZ transcodetherapeutics.com: Accounting Book Value Bawat Bahagi

Grapikong logo ng TransCode Therapeutics, Inc. (RNAZ)

Ang TransCode Therapeutics ay bumubuo ng makabagong TTX system para sa target na pagwasak ng mga metastases. Ang book value per share ay nagpapakita ng capital dynamics, kung saan ang -27.27 ay kumakatawan sa kasalukuyang antas ng metric. Ang operating model ay nakabase sa external molecule synthesis at outsourced research. Ang kawalan ng commercial sales at ang maagang yugto ng pag-unlad ay nagiging sanhi upang ang stock price ay maging dependent sa mga bagong pamumuhunan.

Stockholders Equity Bawat Bahagi TransCode Therapeutics (RNAZ): para sa panahong 04.07.2022 - 26.10.2026

RNAZ (TransCode Therapeutics Inc.): mga analytical breakdown at ulat batay sa indicator

- presyo at pagtataya ng pinagkasunduang presyo:
Presyo ng Stock TransCode|RNAZ - Konsensus na Pagtataya ng Analyst
- datos sa market capitalization:
Pagtatasa ng Merkado TransCode Therapeutics, Inc.|RNAZ - Buong Halaga ng Negosyo
- datos sa book capitalization:
Book Value Bawat Bahagi TransCode Therapeutics|RNAZ - Accounting Capitalization|Ratio ng Halaga sa Pamilihan sa Halaga sa Libro transcodetherapeutics.com|RNAZ - Kabuuang Asset ng Negosyo
- datos sa utang at liquidity:
Kabuuang Utang sa Kapital TransCode Therapeutics|RNAZ - Pangmatagalang utang sa kapital|Ratio ng panandaliang utang sa equity TransCode|RNAZ - Kumulatibong pagkakautang ng kumpanya|Ratio ng utang sa book capitalization TransCode Therapeutics, Inc.
Fundamental valuation ng kumpanya:RNAZ transcodetherapeutics.com
Mga produktong ginagawa ng TransCode Therapeutics

Ang book value ay sumasalamin sa net assets ng kumpanya minus lahat ng liabilities, na nagtatakda ng intrinsic value bawat siyer upang masuri kung sobra ang ibinayad ng investor. Ang pagsusuri sa iniulat na book value bawat siyer ay nagpapakita kung paano sinusuportahan ng asset capitalization ng TransCode Therapeutics (RNAZ) ang RNA drug R&D pipeline sa gitna ng isang mahabang academic cycle ng preclinical research nang walang operating profit.

Mga kakumpitensya ng TransCode Therapeutics (RNAZ)

Tempus AI, Inc. - Book Value Bawat Bahagi|Qiagen Corp (QGEN) - Book Value Bawat Bahagi|Accounting Book Value Bawat Bahagi Ionis Pharmaceuticals (IONS)|repligen.com (RGEN) - Book Value ng Bahagi|Book Value Bawat Bahagi Avidity Biosciences, Inc. (RNA)|Stockholders Equity Bawat Bahagi CRSP|Netong Asset Bawat Isang Bahagi Sema4 WGS|Stockholders Equity Bawat Bahagi Ultragenyx Corp (RARE)|Book Value Bawat Bahagi BEAM (Beam Therapeutics Inc.)|SRPT - Book Value Bawat Bahagi|Accounting Book Value Bawat Bahagi Twist Bioscience, Inc. TWST|TXG: Book Price ng Bahagi|Netong Asset Bawat Isang Bahagi Intellia NTLA|Stoke Corp (STOK) - Accounting Value ng Bahagi|BLFS (BioLife Solutions, Inc.) - Book Value Bawat Bahagi|Book Value Bawat Bahagi WVE|Netong Asset Bawat Isang Bahagi Maze Therapeutics MAZE|Stockholders Equity Bawat Bahagi SION (Sionna Therapeutics, Inc.)|Netong Asset Bawat Isang Bahagi PRME|Net Assets Bawat Bahagi Taysha Corp TSHA|QURE: Book Value Bawat Bahagi|MGTX: Accounting Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi RGNX|Solid Biosciences Inc (SLDB) - Net Asset Value Bawat Bahagi|Book Value Bawat Bahagi Ocugen Corp (OCGN)|Stockholders Equity Bawat Bahagi PacBio Corp|Benitec Biopharma Inc. - Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi designtx.com DSGN|Accounting Book Value Bawat Bahagi Rocket Pharmaceuticals, Inc.|FDMT - Accounting Value ng Bahagi|Accounting Book Value Bawat Bahagi Lexeo LXEO|KRRO - Book Price ng Bahagi|Book Value Bawat Bahagi Editas Medicine, Inc. EDIT|silence-therapeutics.com (SLN) - Accounting Value ng Bahagi|Book Value Bawat Bahagi PRQR (ProQR)|Net Asset Value Bawat Bahagi CDXS|Sangamo (SGMO) - Netong Asset Bawat Isang Bahagi|Accounting Value ng Bahagi nautilus.bio (NAUT)|Book Value Bawat Bahagi MGX (Metagenomi, Inc.)|Precision BioSciences Inc. - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Generation Bio Corp|BOLD - Book Value ng Bahagi|Book Value Bawat Bahagi XCUR|Net Asset Value Bawat Bahagi Imunon|PHIO (Phio Pharmaceuticals Corp) - Accounting Book Value Bawat Bahagi|Book Value Bawat Bahagi Mustang Bio Corp (MBIO)|Accounting Book Value Bawat Bahagi Bionano Genomics, Inc.|Book Price ng Bahagi Applied DNA Sciences Inc (APDN)|Book Value Bawat Bahagi BLUE|Net Assets Bawat Bahagi ImmunoPrecise Antibodies Ltd IPA|OMGA: Book Value Bawat Bahagi|OMIC: Accounting Book Value Bawat Bahagi|Regulus Therapeutics Inc. - Netong Asset Bawat Isang Bahagi|SYRS (Syros Pharmaceuticals Inc.) - Net Assets Bawat Bahagi|TBIO - Netong Asset Bawat Isang Bahagi|Accounting Value ng Bahagi TCON|Netong Asset Bawat Isang Bahagi Unity Biotechnology UBX